Implants News and Research

RSS

DSM Biomedical expands resources and operations in the U.S. and Europe

DSM Biomedical, a global leader in biomedical materials science, today announced the expansion of its resources and operations in the United States and Europe to support the growing demand for the company’s portfolio of innovative polyurethanes for chronically implanted medical devices in the regions.

23 Mar 2010

Medical Facilities' service revenue increases from $199.4M in 2008 to $207.4M in 2009

Medical Facilities Corporation, today reported its financial results for the three and twelve-month periods ended December 31, 2009. All amounts are expressed in U.S. dollars unless indicated otherwise.

22 Mar 2010

Cameron Health initiates clinical trial of minimally invasive S-ICD System for patients at risk of SCA

Cameron Health, Inc. today announced the commencement of the company's pivotal clinical trial to gain U.S. approval of its Subcutaneous Implantable Defibrillator (S-ICD®) System. The minimally invasive S-ICD System is prescribed for use in patients at risk of Sudden Cardiac Arrest (SCA). The S-ICD System is unique in that the implantation of the system is entirely subcutaneous; no leads are in or on the heart.

19 Mar 2010

Scientific revelations discovered during Retina Implant’s first human clinical trial

Retina Implant, AG, a leading developer of subretinal implants for the visually impaired, today announced scientific revelations discovered during the company’s first human clinical trial. The results achieved in the 11 patients that were involved in the trial exceeded the company’s expectations for their first trial.

18 Mar 2010

ForSight Labs licenses non-core ophthalmology technology from SurModics

SurModics, Inc., a leading provider of drug delivery and surface modification technologies to the healthcare industry, announced today that it has entered into an agreement with ForSight Labs, LLC to license certain non-core ophthalmology technology. The technology licensed in this agreement does not include the Company’s I-vation™ drug delivery technology. While the license agreement contains an up-front license fee, milestone payments and royalties, specific terms of the agreement were not disclosed.

18 Mar 2010

Access MediQuip enhances Recall Management Service for implantable devices

Access MediQuip, LLC, the nation's first and largest provider of outsourced implantable medical device management solutions to the healthcare industry, announced today it has enhanced its proprietary Recall Management Service, "RMS," for its customers nationwide. The new release is designed to protect patients, inform and empower surgeons and facilities, and help payers improve quality while managing cost.

17 Mar 2010

Enrollment in patient study to evaluate Magellan DART System for Annular Repair completed

Magellan Spine Technologies, Inc. today announced it had completed enrollment in a twenty patient study to evaluate the Magellan DART (Disc Annular Repair Technology) System for Annular Repair following lumbar discectomy procedures. This first study demonstrates evidence that the DART technology is safe and patients implanted with the DART have excellent outcomes approaching one year follow-up.

16 Mar 2010

PERSEUS clinical program comparing TAXUS Element Stent to prior-generation stents: 12-month results

Angiotech Pharmaceuticals, Inc. today announced that its corporate partner, Boston Scientific Corporation, announced 12-month results from its PERSEUS clinical program that demonstrated positive safety and efficacy outcomes in workhorse lesions for the platinum chromium TAXUS(R) Element(TM) Paclitaxel-Eluting Stent System compared to the TAXUS(R) Express(TM) Paclitaxel-Eluting Stent System.

16 Mar 2010

Positive results from second phase of ABSORB clinical trial on BVS technology

Abbott today announced positive 30-day results from the first 101 patients enrolled in the second phase of the ABSORB trial. Patients treated with Abbott's bioresorbable vascular scaffold (BVS), under clinical investigation in Europe, demonstrated no cases of blood clots (thrombosis), no need for repeat procedures (ischemia-driven target lesion revascularization) and a very low rate of major adverse cardiac events (MACE(1) rate of 2.0 percent) at 30 days.

15 Mar 2010

Bone implants that support and release chemotherapeutical agents in ciclodextrin nanocapsule

Chemotherapy, followed by the surgical removal of the affected tissue is the treatment usually adapted to bone tumors. An implant which can fill the areas of subtraction, while releasing chemotherapeutical agents locally, in a controlled manner, during the treatment period, is the aim of a research led by the Research Centre in Ceramic Material and Composites (CICECO/UA). In these experiences, specialists are using potential "anti-tumor" drugs coated by nanocapsules.

15 Mar 2010

Painful periods at early age doubles risk of endometriosis

Queensland Institute of Medical Research scientists have identified a new link between strong period pain experienced in adolescence and early adulthood and the risk of endometriosis.

15 Mar 2010

Medtronic commences clinical evaluation of CoreValve transcatheter aortic valve system

Moving to expand the evidence base for the future of structural heart disease therapy, Medtronic, Inc., today announced the start of the first of several new initiatives in a robust international clinical program for its CoreValve transcatheter aortic valve system, a minimally-invasive alternative to open-heart surgery for aortic valve replacement.

15 Mar 2010

Study finds implant durability not affected by high-impact sports participation

Total knee arthroplasty (TKA) patients may be able to participate in high-impact sports without increasing risk of early implant failure, according to a new study presented today at the 2010 Annual Meeting of the American Academy of Orthopaedic Surgeons (AAOS).

15 Mar 2010

Zimmer Holdings showcases Continuum Acetabular Cup System at AAOS 2010

Zimmer Holdings, Inc., a leader in musculoskeletal care, today showcased its recently introduced Continuum Acetabular Cup System at the American Academy of Orthopaedic Surgeons (AAOS) annual meeting. The Continuum Cup combines the best of Zimmer's proven hip technologies – Trabecular Metal™ Technology, Metasul® Metal-on-Metal technology, BIOLOX® delta and Longevity® Highly Crosslinked Polyethylene – with new innovations in what is now the company's most versatile acetabular cup system.

12 Mar 2010

Vertos Medical announces positive results from IRB I Patient Outcomes Trial of 'mild' for LSS

Medical device company Vertos Medical Inc. has announced the release of positive results from its U.S. IRB I Patient Outcomes Trial, a prospective, investigational review board-approved, 75-patient study of mild for the treatment of lumbar spinal stenosis (LSS). Six-week clinical data have shown that patients treated with mild experience statistically and clinically significant improvement in both pain and functional ability. The data also confirmed mild’s safety, with no reports of patient complications related to the procedure or the devices.

12 Mar 2010

U.S. commercial launch of Integra Spine's Paramount PS Fixation System announced

Integra LifeSciences announced today the U.S. commercial launch of Integra Spine's Paramount® Pedicle Screw (PS) Fixation System for minimally invasive spine surgery. Previously, the Paramount® PS system was available to a select group of Paramount® PS users. With the completion of a national training effort, the Paramount® PS system is now available nationwide through Integra Spine's independent distribution network.

12 Mar 2010

$Stryker's Orthopaedics Division releases three new plating systems for bone fracture repair$

Stryker's Orthopaedics Division releases three new plating systems for bone fracture repair

Stryker Corporation's Orthopaedics Division today announced the release of three new plating systems: the VariAx Elbow Locking Plate System, the VariAx Fibula Locking Plate System and the AxSOS Extremity Plating System, which are all designed to expand the range of treatment options for bone fracture repair.

From Stryker 12 Mar 2010

New micromanipulator for precise operations involving cochlear and middle ear implants

A team of engineers from the CEIT-IK4 technological centre and doctors from the University Hospital of Navarra have designed a new tool for operating on the inner ear with maximum precision, reducing the possibility of damage to the auditory function during the surgery. This is the first micromanipulator specifically for operations involving cochlear and middle ear implants, of which about a hundred are carried out in this hospital annually. Taking part in developing the new tool were four engineers from CEIT and five ear, nose and throat specialists from the University Hospital of Navarra.

12 Mar 2010

FDA warns healthcare professionals about bogus surgical mesh products

The U.S. Food and Drug Administration today warned health care providers and consumers about counterfeit surgical mesh being distributed in the United States under the C. R. Bard/Davol brand name. Surgical mesh products are used to reinforce soft tissue where weakness exists.

11 Mar 2010

Zimmer Holdings showcases Zimmer Patient Specific Instruments at AAOS 2010

Zimmer Holdings, Inc., a leader in musculoskeletal care, today showcased its recently released Zimmer® Patient Specific Instruments® (PSI) at the American Academy of Orthopaedic Surgeons annual meeting in New Orleans.

11 Mar 2010

Implants News and Research

DSM Biomedical expands resources and operations in the U.S. and Europe

Medical Facilities' service revenue increases from $199.4M in 2008 to $207.4M in 2009

Cameron Health initiates clinical trial of minimally invasive S-ICD System for patients at risk of SCA

Scientific revelations discovered during Retina Implant’s first human clinical trial

ForSight Labs licenses non-core ophthalmology technology from SurModics

Access MediQuip enhances Recall Management Service for implantable devices

Enrollment in patient study to evaluate Magellan DART System for Annular Repair completed

PERSEUS clinical program comparing TAXUS Element Stent to prior-generation stents: 12-month results

Positive results from second phase of ABSORB clinical trial on BVS technology

Bone implants that support and release chemotherapeutical agents in ciclodextrin nanocapsule

Painful periods at early age doubles risk of endometriosis

Medtronic commences clinical evaluation of CoreValve transcatheter aortic valve system

Study finds implant durability not affected by high-impact sports participation

Zimmer Holdings showcases Continuum Acetabular Cup System at AAOS 2010

Vertos Medical announces positive results from IRB I Patient Outcomes Trial of 'mild' for LSS

U.S. commercial launch of Integra Spine's Paramount PS Fixation System announced

Stryker's Orthopaedics Division releases three new plating systems for bone fracture repair

New micromanipulator for precise operations involving cochlear and middle ear implants

FDA warns healthcare professionals about bogus surgical mesh products

Zimmer Holdings showcases Zimmer Patient Specific Instruments at AAOS 2010

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Latest News